Evidence map›Paper›PMID 40983642›Full record

ArticleEuropean journal of human genetics : EJHG2025

Further phenotypical delineation of DLG3-related neurodevelopmental disorders.

Marlène Malbos, Thierry Gautier, Amelle Shillington, Estelle Colin, Xavier Le Guillou, Oana Caluseriu, Bertrand Isidor, Benjamin Cogné, Cyril Mignot, Boris Keren and 27 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Marlène MalbosCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France. marlene.malbos@chu-dijon.fr.ORCID 0009-0005-6258-1706
Thierry GautierUniversité Grenoble Alpes, Inserm U1209, CNRS UMR5309, Institut pour l'Avancée des Biosciences, Grenoble, France.
Amelle ShillingtonCincinnati Children's Hospital Medical Center Department of Human Genetics, Cincinnati, OH, USA.ORCID 0000-0002-7447-8117
Estelle ColinService de Génétique Médicale, CHU Angers, Angers, France.ORCID 0000-0001-7913-3938
Xavier Le GuillouService de Génétique Médicale, CHU de Poitiers, Poitiers, France.ORCID 0000-0001-9350-8177
Oana CaluseriuDepartment of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
Bertrand IsidorService de Génétique Médicale, CHU de Nantes, Nantes, France.
Benjamin CognéService de Génétique Médicale, CHU de Nantes, Nantes, France.ORCID 0000-0002-5503-6292
Cyril MignotCentre de Génétique, CRMR "Déficiences Intellectuelles de Causes Rares", GH Pitié Salpêtrière et Hôpital Trousseau, AP-HP, Paris, France.
Boris KerenCentre de Génétique, CRMR "Déficiences Intellectuelles de Causes Rares", GH Pitié Salpêtrière et Hôpital Trousseau, AP-HP, Paris, France.
Sacha WeberService de Génétique Médicale, CHU Caen Normandie, Caen, France.
Clémence JacquinService de Génétique, CRMR "Anomalies du Développement et syndromes malformatifs", CHU Reims, Reims, France.
Tracy DuddingHunter Genetics, Waratah, NSW, Australia.
Daniel CalameDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA.ORCID 0000-0001-6860-372X
Juliette PiardInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.ORCID 0000-0001-5244-5325
Jonathan LevyCentre de Génétique, AP-HP-Hôpital Robert Debré, Université de Paris, Paris, France.ORCID 0000-0002-8822-816X
Xenia LatypovaCentre de Génétique, AP-HP-Hôpital Robert Debré, Université de Paris, Paris, France.
Alain VerloesCentre de Génétique, AP-HP-Hôpital Robert Debré, Université de Paris, Paris, France.ORCID 0000-0003-4819-0264
Tanguy NiclassCentre de génétique, GH Littoral Atlantique, hôpitaux La Rochelle Ré Aunis, La Rochelle, France.
Aurélia JacquetteCentre de Génétique, CHICAM, Alençon, France.
Lori WhiteCincinnati Children's Hospital Medical Center Department of Human Genetics, Cincinnati, OH, USA.
Marie-Pierre MoizardService de Génétique, CHU de Tours, Tours, France.
Hélène DollfusInserm UMRS_1112, Institut de Génétique Médicale D'Alsace, Université de Strasbourg, France et CHRU, Strasbourg, France.ORCID 0000-0002-2249-895X
Sébastien MouttonCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.ORCID 0000-0002-8942-6731
Julian DelanneCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Caroline RacineCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.ORCID 0000-0003-2378-5982
Quentin ThomasCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.ORCID 0000-0003-1185-1663
Anne-Sophie Denommé-PichonInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.ORCID 0000-0002-8986-8222
Frédéric Tran Mau-ThemInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.ORCID 0000-0002-3795-9456
Ange-Line BruelInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.ORCID 0000-0002-0526-465X
Hana SafraouInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.
Christophe PhilippeInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.ORCID 0000-0001-7098-6520
Yannis DuffourdInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.
Christel Thauvin-RobinetCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.ORCID 0000-0002-4155-139X
Jérôme GovinUniversité Grenoble Alpes, Inserm U1209, CNRS UMR5309, Institut pour l'Avancée des Biosciences, Grenoble, France.ORCID 0000-0001-5511-6965
Antonio VitobelloInserm UMR1231 GAD, Université Bourgogne Europe, FHU Translad, Dijon, France.ORCID 0000-0003-3717-8374
Laurence FaivreCentre de Génétique, CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", "GenoPsy" et "Neurogène", FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.ORCID 0000-0001-9770-444X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SAP102, a member of the membrane-associated guanylate kinase proteins family, is a scaffolding protein encoded by the DLG3 gene whose hemizygous variants with loss-of-function effect are associated with X-linked Intellectual developmental disorder 90. We gathered international data from 17 new individuals with 16 different DLG3 variants (10 with pathogenic loss-of-function and 6 variants of uncertain significance), and reviewed genotypic and phenotypic data from 37 previously published families with 34 different variants. Using family segregation, frequency in publication databases, protein structure modelling and in silico prediction scores, we reclassified six missense variants (five from the literature and one common to our cohort and the literature) as likely benign. Among the individuals newly reported with likely pathogenic or pathogenic DLG3 variants, intellectual disability was more frequently associated with morphological features than in the literature, leading to a proposed extension of the associated X-linked intellectual developmental disorder 90 to a more syndromic neurodevelopmental disorder. In conclusion, we provide here an international clinical series of novel individuals with DLG3 variants in order to better define the clinical and molecular spectrum associated with this condition, and a review of the literature.

Indexed as

Guanylate KinasesNeurodevelopmental DisordersPhenotypeX-Linked Intellectual DisabilityAdolescentChildChild, PreschoolFemaleHumansMaleNuclear ProteinsTranscription FactorsDLG3 protein, humanGuanylate KinasesNuclear ProteinsTranscription Factors

Identifiers

PMID40983642
PMCPMC12669677

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.